Myosin light chain composition in non-failing donor and end-stage failing human ventricular myocardium

Adv Exp Med Biol. 2003:538:3-15. doi: 10.1007/978-1-4419-9029-7_1.

Abstract

The increased Ca(2+)-responsiveness in end-stage human heart failure cannot be attributed to contractile protein isoform changes, but rather is the complex resultant of changes in degree of phosphorylation of VLC-2 and TnI. Despite the decreased basal level of VLC-2 phosphorylation the response to VLC-2 dephosphorylation is enhanced in failing myocytes, which might result from differences in endogenous phosphorylation of thin and thick filament proteins between donor and failing hearts. Taken together decreased VLC-2 phosphorylation in end-stage human heart failure might represent a compensatory process leading to an improvement of myocardial contractility by opposing the detrimental effects of increased Ca(2+)-responsiveness of force and impaired Ca(2+)-handling on diastolic function.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Calcium / metabolism
  • Heart Failure / pathology
  • Heart Ventricles / pathology*
  • Humans
  • Models, Biological
  • Models, Chemical
  • Myocardium / cytology*
  • Myosin Light Chains / chemistry*
  • Phosphorylation
  • Protein Isoforms
  • Pyrazoles / metabolism
  • Pyrimidines / metabolism

Substances

  • 4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3,4-d)pyrimidine
  • Myosin Light Chains
  • Protein Isoforms
  • Pyrazoles
  • Pyrimidines
  • Calcium